Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to assess the need for ongoing therapy. However, little is known about the effectiveness of restabilization with IVIG in patients who worsen after IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Mielke, Orell, Bril, Vera, Cornblath, David R., Lawo, John‐Philip, van Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Merkies, Ingemar S.J., Sobue, Gen, Durn, Billie, Shebl, Amgad, van Schaik, Ivo N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2019
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593755/
https://www.ncbi.nlm.nih.gov/pubmed/30672067
http://dx.doi.org/10.1111/jns.12303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593755/
https://www.ncbi.nlm.nih.gov/pubmed/30672067
http://dx.doi.org/10.1111/jns.12303

Ejemplares similares